Birge Berns

Birge Berns, MD, MRCP, FFPM has a diverse work experience spanning over several years. Currently, they are a Senior Partner at tranScrip, where they provide strategic oversight and leadership for projects in all stages of clinical development. Birge also offers expertise in clinical and regulatory strategy, as well as supporting business development and scientific exchange. In addition to their role at tranScrip, they work as an Academic Consultant, providing consultation and scientific lectures to healthcare providers and supporting change management.

Previously, Dr. Berns has held multiple senior positions at Johnson & Johnson. As the Senior Director of European Regulatory Affairs Oncology, they were responsible for overseeing regulatory affairs in the field of oncology. Birge also served as the Actelion Regulatory Integration Lead and the Global Regulatory Leader for Immunology at Janssen R&D, where they developed compound and regulatory strategies and successfully negotiated with global health authorities.

Prior to their time at Johnson & Johnson, Dr. Berns worked as a Senior Clinical Research Physician at Eisai EMEA and as a Clinical Research Physician/Study Manager at Hoechst. Birge started their career in the NHS as a Clinical House Officer/Registrar.

Overall, Dr. Birge Berns has a wealth of experience in clinical development, regulatory affairs, and strategic leadership, contributing significantly to the pharmaceutical industry throughout their career.

Birge Berns, MD, MRCP, FFPM, has an extensive education history. Birge obtained their Physikum degree in Pre-Medicine/Pre-Medical Studies from Universität des Saarlandes. Birge pursued their medical degree, Doctor of Medicine - MD, in Forensic Immunology at FAU Erlangen-Nürnberg, completing it in 1986. Alongside their medical degree, they also earned a Bachelor of Medicine, Bachelor of Surgery - MBBS equivalent. In 1992, Birge Berns obtained their MRCP degree in Internal Medicine from the Royal College of Physicians, UK. Continuing their education, they completed a Master of Science - MSc degree in Pharmaceutical Medicine at the University of Surrey from 1994 to 2000. Birge further specialized in Oncology, earning another MSc degree from the University of London between 2009 and 2014. Lastly, in 2015, they obtained a Fellowship (FFPM) from the Faculty of Pharmaceutical Medicine, UK.